Project Grant R01CA300794
Award Date 6/1/26
Completion Date 5/31/31
Dollars Obligated $702K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
- Federal Project Grant Award Summary New York University received a $442,750 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), with performance extending from September 23, 2025 through August 31, 2027. This research initiative delivers a systematic, theory-driven analysis of implementation strategies for cervical cancer control policies in African low- and middle-income countries (LMICs). The project employs a rigorous...
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $204,027 project grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), effective August 1, 2025 through July 31, 2030. This award supports the development and application of advanced single-cell and spatial technologies designed to link clonal genotypes with phenotypes during cancer evolution. The project addresses a critical gap in cancer research by...
- Federal Grant Award Summary Weill Medical College of Cornell University received a $169,291 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), effective May 1, 2026 through April 30, 2028. The grant supports research to characterize the cooperative role of E2F1 (a transcription factor) and its interacting proteins in driving advanced prostate cancer, specifically focusing on neuroendocrine prostate cancer (NEPC)...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $627,148 to the University of Maryland, College Park on August 5, 2025, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop an image-guided ethyl cellulose ethanol ablation therapy for treating cervical dysplasia in low and middle-income countries (LMICs). The project, extending through July 31, 2030, builds upon prior Small Business Innovation Research (SBIR) funding...
- Federal Grant Award Summary Wayne State University received a $155,000 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded May 1, 2026, with completion targeted for April 30, 2028. The research project addresses cervical cancer (CC) prevention by assessing multi-level predictors of diagnostic follow-up (DFU) attendance after abnormal cervical cancer screening. While the United States has made progress toward human...
- Federal Project Grant Award Summary Award Details: Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a $3.28 million Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393). The award was obligated on August 15, 2025, with a project completion date of July 31, 2029. Products and Services: The funded project will develop and deliver English and Spanish-language smartphone-based Embodied...
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $401,829 Project Grant award from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396), effective September 1, 2025, through August 31, 2028. The award funds the development of innovative single-cell molecular footprinting methodologies to map chromatin-associated protein activity in cancer cells. Specifically, the research introduces Docking & Deamination Plus...
- Federal Grant Award Summary Cleveland Clinic Lerner College of Medicine of Case Western Reserve University received a $404,974 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period September 1, 2025 through August 31, 2027. The award supports research evaluating the adoption, implementation, and maintenance of thermal ablation (TA) as a cervical precancer treatment in El Salvador. This research addresses a critical...
- Federal Grant Award Summary The National Cancer Institute awarded a $371,161 Project Grant to the University of Colorado-Denver under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) on September 1, 2025, for a two-year performance period concluding August 31, 2027. The award funds the development of artificial intelligence (AI) algorithms designed to improve cervical cancer screening in low-resource settings. Specifically, the project will create advanced AI risk stratification...
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $472,730 project grant award from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), effective August 1, 2025, through July 31, 2030. This five-year project investigates the role of the tumor suppressor KEAP1 (Kelch-like ECH-associated protein 1) in antitumor immunity, with specific focus on understanding how loss-of-function KEAP1 mutations contribute to immune...